Tampere March 5, 2018 – Combinostics and Siemens Healthineers today announced a partnership around distribution of Combinostics’ cNeuro® cMRI application through the Siemens Healthineers Digital Ecosystem. The recently FDA 510(k) cleared quantification software cNeuro® cMRI enables clinicians to get objective measurements of atrophy in different brain regions as well as information about amount of white matter hyperintensities, which is particularly useful in dementia and other neurodegenerative diseases. The software quantifies 133 brain regions and calculated volumes are compared to a normative database. The statistical comparison allows clinicians to quickly get an overview of whether there is abnormal atrophy or white matter changes, and in what brain regions.  The integration of cNeuro® cMRI into Siemens Healthineers Digital Ecosystem allows its users to seamlessly upload images to cNeuro® cMRI, view results and save a report.

Lennart Thurfjell, CEO of Combinostics commented: “Artificial intelligence, AI, is a hot topic promising major changes in medicine. Our goal is to provide AI solutions that help physicians in their daily decision making in neurology. Being part of the Siemens Healthineers Digital Ecosystem is a tremendous opportunity for us as it allows us to get our products out to end users without having to solve integration with hospital PACS and other healthcare IT systems”.

The open and secured environment of the Digital Ecosystem from Siemens Healthineers is the right place to provide innovations like that. It effectively integrates and interconnects data and knowledge from a global and diverse network of healthcare stakeholders.

“The spectrum of members’ data, capabilities, digital offerings and access points to the Digital Ecosystem keeps growing and allows healthcare providers worldwide to harness the power of healthcare going digital. We will generate unprecedented insights through our own offerings as well as through innovative digital health partners like Combinostics. The goal is to help customers using data to deliver value based care with better outcomes at lower costs. We are very excited to welcome Combinostics to our Digital Ecosystem”, said Alexander Lippert, Head of Digital Ecosystem at Siemens Healthineers.

About Combinostics

Combinostics is a Finnish digital health company that develops and markets advanced tools for data-driven diagnostics. The technology is generic and can be applied to any disease area but Combinostics’ first application concerns early detection and differential diagnostics in Alzheimer’s disease and other dementias. Combinostics’ cNeuro® platform includes cMRI for quantification of MRI brain scans and cDSI for data-driven clinical decision support in dementia. cNeuro® cMRI and cDSI have been certified according to the European Medical Device Directive (93/42/EEC) and are available for clinical use in Europe and cNeuro® cMRI is FDA 510(k) cleared.

Contact: Lennart Thurfjell, lennart.thurfjell@combinostics.com, +46 730 699057

About the Siemens Healthineers Digital Ecosystem

 The Digital Ecosystem from Siemens Healthineers provides an open and secured environment for digitalizing healthcare. It effectively integrates and interconnects data and knowledge from a global and diverse network of healthcare stakeholders. Digital offerings developed by members of the Siemens Healthineers Digital Ecosystem will help to increase decision making capabilities based on data-driven insights. A dedicated store for digital offerings from Siemens Healthineers and as well its partners will allow users to quickly assess the different offerings and the use cases they serve. It supports healthcare institutions to efficiently purchase and deploy digital health offerings within their setting.

Contact: siemens.com/healthineers-digital-ecosystem